(Q39867138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Chronic obstructive pulmonary disease phenotypes: the future of COPD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

4 February 2020

main subject

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

William MacNee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Leonardo M. Fabbri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jonathan Goldin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Frank Sciurba

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jørgen Vestbo

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

18

Emiel F M Wouters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

19

Fernando J Martinez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

MeiLan K Han

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

13

Stephen I Rennard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

17

George R Washko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

5

Gerard Criner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

11

Barry J Make

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

4

Bartolome R Celli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

3

Peter M Calverley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Alvar Agusti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Paul W Jones

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Klaus F Rabe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Edwin K Silverman

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

3 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

598-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Definition of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Phenotypes of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The natural history of chronic airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Gender and chronic obstructive pulmonary disease: why it matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The association between depressive symptoms and acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Exercise testing in severe emphysema: association with quality of life and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Prevalence and clinical correlates of bronchoreversibility in severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Genetic association analysis of functional impairment in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Clinical significance of radiologic characterizations in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Airflow limitation and airway dimensions in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

New and current clinical imaging techniques to study chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Predictors of mortality in patients with emphysema and severe airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Physiological changes during symptom recovery from moderate exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

COPD as a disease of accelerated lung aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Inflammation markers predicting frailty and mortality in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

The SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Triple-negative/basal-like breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Eosinophils in asthma--closing the loop or opening the door?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Distinct clinical phenotypes of airways disease defined by cluster analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Development and Validation of a Prognostic Index for Health Outcomes in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1843CC

Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD?

21 January 2018

1 reference

12 December 2020

Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease

1 reference

12 December 2020

Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function

1 reference

12 December 2020

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease

1 reference

12 December 2020

Determinants of maximum exercise capacity in patients with chronic airflow obstruction

1 reference

12 December 2020

The modified BODE index: validation with mortality in COPD

1 reference

12 December 2020

Contribution of emphysema and small airways in COPD

1 reference

12 December 2020

Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD

1 reference

12 December 2020

Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD

1 reference

12 December 2020

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

1 reference

12 December 2020

10.1164/RCCM.200912-1843CC

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20522794%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

20522794

1 reference